|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
EP0903344B1
(en)
*
|
1997-08-21 |
2011-01-26 |
Shiseido Co., Ltd. |
Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin
|
|
US6436919B1
(en)
|
1999-10-01 |
2002-08-20 |
Theravance Inc. |
Local anesthetic compounds
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
EP2223922B1
(en)
*
|
2000-04-25 |
2016-03-02 |
ICOS Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
EP2329822A1
(en)
|
2001-09-05 |
2011-06-08 |
Minerva Biotechnologies Corporation |
Compositions and methods of treatment of cancer
|
|
CA2459584A1
(en)
*
|
2001-09-05 |
2003-03-13 |
Cynthia C. Bamdad |
Compositions and use thereof in the treatment of cancer
|
|
WO2003039460A2
(en)
*
|
2001-11-07 |
2003-05-15 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
EP1539180A4
(en)
*
|
2002-08-21 |
2006-08-30 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
US20060052345A1
(en)
*
|
2002-11-04 |
2006-03-09 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
|
ATE440825T1
(de)
*
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
|
|
WO2005016349A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methods of inhibiting leukocyte accumulation
|
|
US20050043239A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
WO2005113554A2
(en)
*
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
|
|
WO2005117889A1
(en)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic
|
|
US20080287469A1
(en)
*
|
2005-02-17 |
2008-11-20 |
Diacovo Thomas G |
Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
|
|
EP2233472B1
(en)
*
|
2006-03-28 |
2014-01-15 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
SG195655A1
(en)
|
2008-11-13 |
2013-12-30 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
CN102439012A
(zh)
|
2009-03-24 |
2012-05-02 |
吉里德卡利斯托加公司 |
2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
|
|
AP2011005956A0
(en)
*
|
2009-04-20 |
2011-10-31 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors.
|
|
CA2768843A1
(en)
|
2009-07-21 |
2011-01-27 |
Gilead Calistoga Llc |
Treatment of liver disorders with pi3k inhibitors
|
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
|
EP2697206B1
(en)
|
2011-04-10 |
2019-04-03 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
PL2834241T3
(pl)
|
2012-03-05 |
2021-07-12 |
Gilead Calistoga Llc |
Formy polimorficzne (s)-2-(1-(9h-puryn-6-yloamino)propylo)-5-fluoro-3-fenylochinazolin-4(3h)-onu
|
|
WO2014009872A1
(en)
|
2012-07-09 |
2014-01-16 |
Lupin Limited |
Tetrahydroquinazolinone derivatives as parp inhibitors
|
|
JP2017500319A
(ja)
|
2013-12-20 |
2017-01-05 |
ギリアード カリストガ エルエルシー |
（ｓ）−２−（１−（９ｈ−プリン−６−イルアミノ）プロピル）−５−フルオロ−３−フェニルキナゾリン−４（３ｈ）−オンの塩酸塩の多形形態
|
|
CA2934531C
(en)
|
2013-12-20 |
2020-02-25 |
Gilead Calistoga Llc |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
|
WO2015191726A1
(en)
|
2014-06-13 |
2015-12-17 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|